Skip to main content
. 2024 Dec 28;43:334. doi: 10.1186/s13046-024-03258-7

Fig. 16.

Fig. 16

Left, GFP-labeled MOs in micro-wells. Right, Patient-derived MOs in a well-plate, ready for drug testing